Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sinovac Research And Development Co., Ltd.

Clinical trials sponsored by Sinovac Research And Development Co., Ltd., explained in plain language.

Now part of Sinovac Biotech Ltd. SVA NASDAQ

A subsidiary of Sinovac Biotech, focused on vaccine research and development.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

New pneumonia vaccine shows promise in early trial for kids

⭐️ VACCINE ⭐️ Completed

This completed phase 1b trial tested a new 13-valent pneumococcal conjugate vaccine (PCV13) in 140 healthy infants (2 months old) and children (2-5 years). The goal was to check safety and immune response compared to an existing vaccine. Researchers monitored side effects and ant…

Phase: PHASE1 • Sponsor: Sinovac Research and Development Co., Ltd. • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 09:00 UTC